Hideki Kamada

ORCID: 0000-0002-0715-645X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Gallbladder and Bile Duct Disorders
  • Pancreatitis Pathology and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pediatric Hepatobiliary Diseases and Treatments
  • Neuroendocrine Tumor Research Advances
  • Gastric Cancer Management and Outcomes
  • Esophageal and GI Pathology
  • Gastrointestinal Tumor Research and Treatment
  • Gastrointestinal disorders and treatments
  • Metabolism, Diabetes, and Cancer
  • Inflammatory Biomarkers in Disease Prognosis
  • Oral and gingival health research
  • Cancer Mechanisms and Therapy
  • MicroRNA in disease regulation
  • Biliary and Gastrointestinal Fistulas
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism
  • Cancer Research and Treatments
  • Foreign Body Medical Cases
  • Helicobacter pylori-related gastroenterology studies
  • Galectins and Cancer Biology
  • Genetic factors in colorectal cancer
  • Cancer-related Molecular Pathways
  • IgG4-Related and Inflammatory Diseases

Kagawa University
2016-2025

Kin-ikyo Chuo Hospital
1995-2017

Okayama Prefecture
2015

The University of Tokyo
2014

Kagawa University Hospital
1972-2012

JR Tokyo General Hospital
2011-2012

Gifu University Hospital
2011-2012

Nagano Municipal Hospital
2012

Gifu Municipal Hospital
2012

Onomichi General Hospital
2012

Endoscopic ultrasound-guided biliary drainage (EUS-BD) can be carried out by two different approaches: choledochoduodenostomy (CDS) and hepaticogastrostomy (HGS). We compared the efficacy safety of these approaches in malignant distal obstruction (MDBO) patients using a prospective, randomized clinical trial.Patients with after failed endoscopic retrograde cholangiopancreatography were randomly selected for either CDS or HGS. The procedures at nine tertiary centers from September 2013 to...

10.1111/den.13406 article EN Digestive Endoscopy 2019-03-25

Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is used for the histopathological diagnosis of any type gastrointestinal disease. Few adverse events are experienced with this procedure; however, actual rate remains unclear. This study aimed to clarify current status cases that related EUS-FNA procedure histopathologic diagnoses.A retrospective analysis EUS-FNA-related in Japanese tertiary centers was conducted by assessing following clinical data: basic case information, FNA...

10.1111/den.13912 article EN Digestive Endoscopy 2020-12-07

Unresectable malignant bile duct stricture (often caused by unresectable pancreatic cancer and cholangiocarcinoma) can be drained via insertion of self-expandable metal stents (SEMS) during endoscopic retrograde cholangiopancreatography (ERCP). Because recurrent biliary obstruction (RBO) complications following stent delay chemotherapy other treatments, a longer time to RBO (TRBO) is desirable. Although TRBO has been reported among patients who undergo with larger diameter SEMS, smaller...

10.1186/s13063-025-08771-4 article EN cc-by-nc-nd Trials 2025-02-18

Carcinoma of the ampulla Vater is uncommon. This study aimed to clarify predictors survival for ampullary adenocarcinoma and identify characteristics its two major pathological subtypes.Medical records were reviewed 86 patients who underwent curative resection between 2000 2012 at 12 principal hospitals in Kagawa, Japan.Resection was most common among 75-79-year-old patients. Actuarial 1-, 3-, 5-year postoperative rates 90%, 72.3%, 69.1%, respectively. Preoperative biliary drainage; serum...

10.1002/jso.23600 article EN Journal of Surgical Oncology 2014-03-12

Abstract Background With the increasing popularity of endoscopic ultrasound (EUS)-guided transmural interventions, walled-off necrosis (WON) pancreas is increasingly managed via non-surgical interventions. However, there has been an ongoing debate over appropriate treatment strategy following initial EUS-guided drainage. Direct necrosectomy (DEN) removes intracavity necrotic tissue, potentially facilitating early resolution WON, but may associate with a high rate adverse events. Given safety...

10.1186/s13063-023-07377-y article EN cc-by Trials 2023-05-24

Hepatitis B virus (HBV)-related hepatocarcinogenesis is not necessarily associated with the liver fibrotic stage and occasionally seen at early stages. MicroRNAs (miRNAs) are essentially 18- to 22-nucleotide-long endogenous noncoding RNAs. Aberrant miRNA expression a common feature of various human cancers. The aberrant specific miRNAs has been shown in hepatocellular carcinoma (HCC) tissue compared nontumor tissue. Thus, we examined targetable as potential new biomarker related high risk...

10.1152/ajpgi.00269.2019 article EN cc-by AJP Gastrointestinal and Liver Physiology 2020-01-06

Objective Stenting is an established endoscopic therapy for malignant gastric outlet obstruction (mGOO). The choice of stent (covered vs uncovered) has been examined in prior randomised studies without clear results. Design In a multicentre prospective study, we compared covered (CSEMS) with uncovered self-expandable metal stents (UCSEMS) patients mGOO; main outcomes were dysfunction and patient survival, subgroup analyses extrinsic intrinsic tumours. Results Overall survival was poor no...

10.1136/gutjnl-2020-320775 article EN cc-by-nc Gut 2020-11-22

Abstract Background The perioperative factors predicting or influencing early pancreatic ductal adenocarcinoma recurrence are unclear. This study attempted to identify the predictive for post-pancreatectomy and influence of pre- post- operative adjuvant therapy. Methods One hundred fifteen patients undergoing curative resection between 2000 2016 at our institution were retrospectively analyzed. Patients divided into two groups: those who did ( n = 34) not 81) experience a within 6 months...

10.1186/s12893-019-0644-z article EN cc-by BMC Surgery 2019-12-01

We review the utility of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA), a rapid, safe, cost-effective, and accurate diagnostic modality for evaluating pancreatic tumors. EUS-FNA is currently used diagnosis staging The sensitivity malignancy ranges from 75% to 94%, its specificity approaches 100% in most studies. However, has some limitations well-differentiated or early-stage cancers. Recent evidence suggests that molecular biological analysis using specimens obtained by...

10.1155/2012/243524 article EN cc-by Gastroenterology Research and Practice 2012-01-01

Abstract Background and study aims Endoscopic ultrasound-guided fine needle aspiration (FNA) for gastrointestinal subepithelial lesions (SELs) has limited diagnostic accuracy due to technical problems small lesion size. We previously reported a novel submucosal tunneling biopsy (STB) technique sampling SELs. This aimed evaluate the ability safety of STB compared that FNA Patients methods The was non-randomized, prospective comparative with crossover design in patients endoluminal gastric...

10.1055/s-0043-112497 article EN cc-by-nc-nd Endoscopy International Open 2017-08-01

Although gemcitabine (2',2'-difluorocytidine monohydrochloride) is a common anticancer agent of cholangiocellular carcinoma (CCC), its growth inhibitory effects and resistance in CCC cells are poorly understood. Our aims were to uncover the mechanism underlying antitumor effect analyze regulating vitro cell resistance. In addition, we sought identify miRNAs associated with CCCs. Using proliferation assay flow cytometry, examined ability inhibit three types human lines (HuCCT-1, Huh28, TKKK)....

10.3892/ijo.2015.3118 article EN International Journal of Oncology 2015-08-07

Gallbladder cancer is the most common biliary tract with poor prognosis and wide variation in incidence rates worldwide, being very high some countries Latin America Asia. Treatment of type 2 diabetes metformin causes a reduction cancer. Till date, there are no reports on anti-tumor effects gall bladder Therefore, this study evaluated proliferation human gallbladder adenocarcinoma cells vitro vivo, as well explored microRNAs associated metformin. Metformin inhibited cell lines NOZ,...

10.1097/cad.0000000000000870 article EN Anti-Cancer Drugs 2019-12-09
Coming Soon ...